scholarly journals Role of genomic DNA methylation in detection of cytologic and histologic abnormalities in high risk HPV-infected women

PLoS ONE ◽  
2019 ◽  
Vol 14 (1) ◽  
pp. e0210289 ◽  
Author(s):  
Wiyada Dankai ◽  
Surapan Khunamornpong ◽  
Sumalee Siriaunkgul ◽  
Aungsumalee Soongkhaw ◽  
Arphawan Janpanao ◽  
...  
Author(s):  
Mimansha Patel ◽  
Madhuri Nitin Gawande ◽  
Minal Shashikant Chaudhary ◽  
Alka Harish Hande

Background: “Oral Potentially Malignant Disorder (OPMD)” is a well-known symptom that, if untreated, can be carcinogenic. It includes leukoplakia, erythroplakia or erythroleukoplakia. One of the typical premalignant lesions of the oral cavity is “oral leukoplakias (OLs),” which frequently precedes “OSCCs.”OLs with dysplastic characteristics are considered to be at a higher risk of “malignant transformation.” So, early diagnosis of "oral squamous cell carcinomas (OSCCs)" is desperately required to enhance patient prognosis and quality of life (QOL).As a result, we examined the distinctive promoter methylation presence in high-risk OLs. Objectives: To detect, compare & correlate “DNA methylation” patterns in normal individuals, tobacco users without disease and tobacco users with the disease. Methodology: With the participants' full consent, 48 saliva samples were obtained and prepared. DNA isolation, restriction digestion of genomic DNA, extraction of restriction enzyme digested genomic DNA, Polymerase Chain Reaction (PCR), and Agarose Gel Electrophoresis (AGE) were all carried out. Expected results: This study will help us to assess the use of Saliva as an aid to identifying both high and low risk “Oral Potentially Malignant Disorders.” Conclusion: Peculiar promoter methylation of various genes was related to a high possibility of malignant transformation in OLs.


Epigenetics ◽  
2018 ◽  
Vol 13 (7) ◽  
pp. 769-778 ◽  
Author(s):  
Wina Verlaat ◽  
Robert W. Van Leeuwen ◽  
Putri W. Novianti ◽  
Ed Schuuring ◽  
Chris J. L. M. Meijer ◽  
...  

Blood ◽  
2010 ◽  
Vol 116 (21) ◽  
pp. 3622-3622
Author(s):  
Yang Liu ◽  
Shenghua Duan ◽  
Xavier Leleu ◽  
Yong Zhang ◽  
Abdel Kareem A. Azab ◽  
...  

Abstract Abstract 3622 Introduction: Epigenetic factors such as DNA methylation have been shown to play a crucial role in the pathogenesis and progression of multiple myeloma (MM), yet studies of DNA methylation in MM are still limited. Therefore, in order to better understand the role of DNA methylation and identify specific genes that may be affected by differential methylation in MM patients, we conducted genome-wide DNA methylation profiling in cd138+ plasma cells purified from bone marrow of the patients with MM and normal donors. Methods: Genomic DNA of CD138+ Plasma cell selected from both MM patients and normal primary bone marrow was extracted using QIAGEN genome isolation kit. Following extraction, methylated DNA was isolated by Chip and hybridized to Affymetrix Human 2.0 tiling arrays. Chip assay and array hybridization was performed by Genepathway Inc. CEL files were processed and normalized using the MAT program, and methylation peaks were called from the resulting MAT scores using a custom segmentation method. Peak annotation and characterization of different genomic regions was done with custom tools and using genome annotation files from the UCSC genome database. All peaks were visualized by IGB online software. Medip-PCR was done in human MM cell lines to validate the methylation status. Methylated gene expression was determined by both Semi-quantitative PCR and real-time PCR. 5′aza was used for demethylation in human MM cell lines. Methylated gene expression with or without 5′aza treatment was determined by both Semi-quantitative PCR and real-time PCR. Results: Genomic DNA from CD138+ plasma cells from bone marrow of MM patients showed a significant increase in methylation levels compared to normal controls. We demonstrated that the hypermethylated sites were distributed across the genome in the following proportions: 3.2% in the promoter region; 45.6% in the intragenic region; 5.4 % in the 3′ end region; and 46.8 % in the intergenic region. Furthermore, around 9 % promoter CpG islands (CGIs); 11% intragenic CGIs; 15 % CGIs in 3′end region; and 14.3 % intergenic CGIs of patients genomic DNA were methylated. Moreover 2.1% promoter CGIs; 2.3 % intragenic CGIs; 2.5% CGIs in 3′end region; and 4.7% intergenic CGIs were methylated for the normal control. Medip-PCR showed that the identified methylation pattern in MM patients showed similar results in MM cell lines. Expectedly, we also observed that suppressor of cytokine signaling 1 (SOCS1) was hypermethylated at the promoter region (MAT score=19.986) as has been reported in human cell lines. Importantly, another member of SOCS family SOCS3 showed much stronger signal in the promoter region with CpG island (MAT score=31.707) in MM patients compared to normal control. Notably, the expression of two members of TNFR superfamily TNFRSF18 and TNFRSF4 which play an important role in development and programmed cell death of lymphocyte significantly have increased 283 and 141-fold after treatment with 5′aza in MM cell lines. Conclusion: These findings enhance our understanding of the role of DNA methylation in MM, as one of the epigenetic changes that may contribute to the pathogenesis of this disease. The identification and functional characterization of novel key molecules affected by DNA methylation will provide deeper insight into the molecular basis of MM disease. Disclosures: Leleu: Celgene: Consultancy, Research Funding; Janssen Cilag: Consultancy, Research Funding; Leo Pharma: Consultancy; Amgen: Consultancy; Chugai: Research Funding; Roche: Consultancy, Research Funding; Novartis: Consultancy, Research Funding. Anderson:Millennium Pharmaceuticals: Honoraria, Membership on an entity's Board of Directors or advisory committees, Research Funding, Speakers Bureau.


2006 ◽  
Vol 85 (9) ◽  
pp. 1114-1119 ◽  
Author(s):  
Janne Tolstrup ◽  
Christian Munk ◽  
Birthe Lykke Thomsen ◽  
Edith Svare ◽  
Adriaan J.C. van den Brule ◽  
...  

2019 ◽  
Vol 32 (4) ◽  
Author(s):  
Dominik Gurín ◽  
Marek Slávik ◽  
Tetiana Shatokhina ◽  
Tomáš Kazda ◽  
Jiří Šáňa ◽  
...  

2020 ◽  
Vol 46 (Supplement_1) ◽  
pp. S32-S33
Author(s):  
Camila Loureiro ◽  
Corsi-Zuelli Fabiana ◽  
Fachim Helene Aparecida ◽  
Shuhama Rosana ◽  
Menezes Paulo Rossi ◽  
...  

Abstract Background Childhood trauma may lead to impairments in brain development and increases risk at psychiatric disorders. Evidence also suggests that childhood trauma may affect DNA methylation patterns consequently influencing gene expression (Tomassi et al., 2017). Some of this linking may be correlated with N-methyl-d-aspartate receptor (NMDAR) hypofunction, which plays a major role of central aspects of cognitive and negative features of schizophrenia (Lakhan et al., 2013). Specifically, the GRIN1 gene codes the biologically relevant NMDAR subunit involved in the synaptic plasticity which is expressed in a broad of non-neuronal cells (Hogan-Cann et al., 2016). Aims: We investigated DNA methylation in the promoter region of GRIN1 and LINE-1 methylation in first-episode psychosis patients (FEP), their unaffected siblings and community-based controls with and without childhood trauma. We also tested for correlations between GRIN1 methylation and NR1 concentrations in peripheral blood. Methods This study is a part of the epidemiological investigation that estimated the incidence of psychosis and the role of environmental and biological factors in psychosis aetiology in the catchment area of Ribeirão Preto, Brazil, from 1st April 2012 to 31st March 2015. The genomic DNA was extracted from blood of 60 FEP patients, 30 of their unaffected siblings and 60 age- and sex-matched community-based controls. Diagnosis and clinical characteristics were assessed using the DSM-IV (First et al., 1997; Del-Ben et al., 2001) and history of childhood trauma was assessed using the Childhood Trauma Questionnaire (Grassi-Oliverira et al., 2006). The genomic DNA was bisulfite converted and pyrosequencing was used to determine methylation levels in three CpGs sites of the GRIN1 gene and of LINE-1, as a measure of global methylation. NR1 plasma concentrations were measured using ELISA (MyBioSource, San Diego, USA). Data were analyzed using General Linear Model with post-hoc Bonferroni correction and Pearson’s correlations. Results Individuals, independent of groups, who had experienced childhood trauma presented higher levels of GRIN1 methylation than those without trauma (CpG1: p=0.004; CpG3: p=0.009). Moreover, individuals with physical neglect demonstrated GRIN1 hypermethylation in comparison to individuals without trauma (CpG1: p=0.027; CpG3: p=0.006). Specifically, siblings with emotional neglect presented increased GRIN1 methylation levels at CpG1 when compared with FEP patients and controls with emotional neglect (p=0.028; p=0.001, respectively) and in relation to siblings without trauma (p=0.004). Siblings with physical neglect also showed increased GRIN1 methylation levels at CpG1 when compared to FEP patients and controls with physical neglect (p=0.010; p=0.003, respectively) and in relation to siblings without physical neglect (p=0.001). Furthermore, FEP patients with emotional neglect showed increased GRIN1 methylation at CpG3 when compared to FEP patients without emotional neglect (p=0.010). No differences were observed in the LINE-1 methylation between individuals with or without childhood trauma. Discussion This is the first study demonstrating the association between DNA methylation in GRIN1 and childhood trauma in FEP patients, their unaffected siblings and community-based controls. In addition, the interaction between DNA methylation changes in GRIN1 and childhood trauma may be a predict factor of susceptibility for siblings. All these findings suggest evidence for NMDAR dysfunction in response to trauma, contributing the understanding of some of the epigenetics mechanisms by which early life stress affects the glutamatergic system.


Author(s):  
C. Aryasomayajula ◽  
A. Chanana ◽  
M. Tandel ◽  
L. Kwan ◽  
J.G. Cohen ◽  
...  

2009 ◽  
Vol 133 (8) ◽  
pp. 1246-1250
Author(s):  
Guru Prasad Manderwad ◽  
Chitra Kannabiran ◽  
Santosh G. Honavar ◽  
Geeta K. Vemuganti

Abstract Context.—Ocular surface squamous neoplasia (OSSN) represents a spectrum of ocular surface tumors ranging from intraepithelial to invasive. The genesis of OSSN is multifactorial, possibly including human papillomavirus (HPV) infection, the role of which is controversial. Objective.—To evaluate the role of high-risk HPV16 and HPV18 in OSSN. Design.—Retrospective and prospective noncomparative case series. In this study, histologically proven cases of OSSN were evaluated in formalin-fixed, paraffin-embedded sections (n = 50) and fresh tissues (n = 7) for the presence of HPV by polymerase chain reaction using MY09/MY11 consensus primers, HPV16 and HPV18 type-specific primers, and in situ hybridization–catalyzed reporter deposition (ISH-CARD). Cervical tumors (n = 19) along with SiHa and HeLa cell lines served as positive controls for HPV analysis. Results.—The study included 48 patients with OSSN who accounted for 57 specimens, with a median patient age of 28.5 years (range, 1.5–70 years). These specimens included 36 squamous cell carcinomas and 21 conjunctival intraepithelial neoplasias. All of the cases were found to be negative for high-risk HPV using polymerase chain reaction and ISH-CARD assay, whereas the SiHa and HeLa cell lines were appropriately positive. Of the cervical tumors that served as positive controls, 18 were positive for HPV16, and 1 was positive for HPV18. Conclusions.—Sensitive, type-specific polymerase chain reaction for detection of HPV16 and HPV18, polymerase chain reaction assay for consensus HPV sequences, and ISH-CARD did not show the presence of high-risk HPV in OSSN. Thus, HPV appears to play no significant role in the etiology of OSSN in India.


Author(s):  
Paulo C. Giraldo ◽  
Jose Eleutério ◽  
Diane Isabelle M. Cavalcante ◽  
Ana Katherine S. Gonçalves ◽  
Juliana A.A. Romão ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document